Company: ORIB
Filing Date: 2025-11-26
Form Type: 10-Q
Source: 0001683168-25-008685
Chunk: 21

Company: Orion Bliss Corp.
Filing Date: 2025-11-26
Form: 10-Q
Item: Item 8
Chunk 21
---
 U.S. statutory rate at 21% for the period ended as follows:

    Schedule of income tax benefit (expense) 

    October 31, 2025 
  
    Tax benefit (expenses) at U.S. statutory rate 
    $(1,448)
  
    Change in valuation allowance 
     1,448 
  
    Tax benefit (expenses), net 
    $– 

The tax effects of temporary differences that give rise to significant
portions of the net deferred tax assets are as follows:

    Schedule of net deferred taxes 

    October 31, 2025 
  
    Net operating loss 
    $(30,088)
  
    Valuation allowance 
     30,088 
  
    Deferred tax assets, net 
    $– 

The Company has accumulated approximately $143,274
of net operating losses (“NOL”) carried forward to offset future taxable income up to 20 years, if any, in future years which
begin to expire in year 2038. In assessing the realization of deferred tax assets, management considers whether it is more likely than
not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent
upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers
the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.
Based on the assessment, management has established a full valuation allowance against all of the deferred tax asset relating to NOLs
for every period because it is more likely than not that all of the deferred tax asset will not be realized.

Note 6 – COMMITMENTS AND CONTINGENCIES

Our sole officer and director, Alexandra Solomovskaya,
has agreed to provide her own premise under office needs. She will not take any fee for these premises it is for free use.

Management expects that its business will be impacted
to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which
it may have an impact cannot be determined at this time.

Note 7 – SUBSEQUENT EVENTS

In accordance with ASC 855-10 the Company has
analyzed its operations subsequent to October 31, 2025 to the date these financial statements were issued, and has determined that it
does not have any material subsequent events to disclose in these financial statements.

 11 

ITEM 2. MANAGEMENT'S